Slingshot members are tracking this event:
AMGN presents results for Repatha (evolocumab) Cardiovascular Outcomes Trial (FOURIER) at the American College of Cardiology 66th Annual Scientific Session
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Mar 17, 2017
Related Keywords Repatha, Evolocumab, American College Of Cardiology, Acc '17, Fourier, Outcomes Trial